Expert panel clears Covishield's emergency use in India

New Delhi, Jan 1 The 10-member Subject Expert Committee of India's Central Drug Standard Control Organisation on Friday approved emergency use authorisation of the Oxford-AstraZeneca coronavirus vaccine 'Covishield'.

The expert panel had convened a meeting to take a call on the emergency use authorisation sought by the Serum Institute of India, the manufacturer of Covishield, and Bharat Biotech for its Covaxin.

Once the vaccines are cleared by the committee, the application will be sent to Drugs Controller General of India (DCGI) V.G. Somani for final approval.